| Symbol | CDNA |
|---|---|
| Name | CAREDX, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medical Specialities |
| Address | 1 TOWER PLACE,9TH FLOOR, SOUTH SAN FRANCISCO, California, 94080, United States |
| Telephone | +1 415 287-2300 |
| Fax | — |
| — | |
| Website | https://www.caredx.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001217234 |
| Description | CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a leading provider of genomics-based information for transplant patients. Its primary operations are in Brisbane, California; Omaha, Nebraska; Fremantle, Australia and Stockholm, Sweden. Additional info from NASDAQ: |
📋 JEFFREY NOVACK (Officer) plans to sell 3K shares of CAREDX, INC. (at $20.96 each, total $56K) Filed: May 05, 2026 | ID: 004064
Read moreNovack Jeffrey Adam 🔴 sold 2.9K shares of CareDx, Inc. (CDNA) at $21.50 Transaction Date: May 01, 2026 | Filing ID: 000004
Read moreCareDx Announces Agreement to Acquire Naveris, A Leader in Viral-Mediated Cancer MRD Surveillance Testing
Read moreNew Form S-3ASR - CareDx, Inc. <b>Filed:</b> 2026-04-28 <b>AccNo:</b> 0001104659-26-050471 <b>Size:</b> 1 MB
Read moreNew Form ARS - CareDx, Inc. <b>Filed:</b> 2026-04-27 <b>AccNo:</b> 0001140361-26-017119 <b>Size:</b> 9 MB
Read moreNew Form DEFA14A - CareDx, Inc. <b>Filed:</b> 2026-04-27 <b>AccNo:</b> 0001217234-26-000029 <b>Size:</b> 4 MB
Read moreNew Form DEF 14A - CareDx, Inc. <b>Filed:</b> 2026-04-27 <b>AccNo:</b> 0001217234-26-000028 <b>Size:</b> 9 MB
Read more